The Spain pharmaceutical market is expected to grow at a CAGR of 5.40% from 2024 to 2032, driven by an aging population, rising R&D investments, increased adoption of generic drugs, and the expansion of biopharmaceuticals. https://www.imarcgroup.com/spain-pharmaceutical-market